Samuel Leopoldo Romero-Guillena

Dr. Samuel Leopoldo Romero-Guillena

Andalusian Health Service, Seville, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
JPJosé Ángel Alcalá Partera
José Ángel Alcalá Partera
AFAndrés Fontalba-Navas
Andrés Fontalba-Navas
Miguel CompanyMiguel Company
Miguel Company
SRSamuel Leopoldo Romero-Guillena
Samuel Leopoldo Romero-Guillena
TGTeófilo Gutiérrez-Higueras
Teófilo Gutiérrez-Higueras
LGLuis Gutiérrez-Rojas
Luis Gutiérrez-Rojas
One of the big challenges in treating individuals with bipolar disorder (BD) is nonadherence to medication. This is the principal factor associated with a worse prognosis or outcome of the disease. This study aimed to explore and analyze the individual perceptions that people with BD have about the positive and negative aspects when taking medication. A descriptive and interpretative study was carried out using the qualitative research paradigm with the use of the analytical technique of discourse analysis, extracting the data through the completion of focus groups. Participants’ speech was digitally audio-recorded in digital format. In order to complete the codification of the participants’ speech content, we relied on the qualitative data analysis (using the QRS NVivo 10 computer software). Thirty-six participants diagnosed with bipolar disorder took part in our study. In the participants’ speech concerning the main barriers to pharmacological treatment, three key topics were identified. Perceived facilitators were summarized in four factors. The main facilitators regarding the use of pharmacological treatment in individuals with BD were the ones related with the perceived need for treatment in the acute phase, the recognition of the illness, the shared clinical decision, and the causal biological attribution in the chronic phase. In terms of perceived barriers, social control was identified in both phases, adverse effects in the acute phase, and the absence of effective treatment in the chronic state.